Market Research Logo

AC Immune SA (ACIU) - Financial and Strategic SWOT Analysis Review

AC Immune SA (ACIU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

AC Immune SA (AC Immune) is a biopharmaceutical company that develops products for treating neurodegenerative diseases. It discovers, designs and develops innovative proprietary medicines to prevent, diagnose and treat neurodegenerative diseases associated with protein misfolding. The company develops drugs based on its two proprietary technology platforms, SupraAntigen and Morphomer. These technology platforms aid in the design, discovery and development of antibodies, small molecules and vaccines. AC Immune’s product pipeline includes nine therapeutic product candidates and three diagnostic product candidates. The company’s lead product candidate, crenezumab is an anti-Abeta antibody being developed in Phase III in collaboration with Genentech for treating Alzheimer’s disease. AC Immune is headquartered in Lausanne, Switzerland.

AC Immune SA Key Recent Developments

May 02,2018: AC Immune Reports First Quarter 2018 Financial Results and Corporate Update
Apr 05,2018: AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer's disease
Mar 20,2018: AC Immune reports full-year 2017 financial results - successful first year as a public company
Feb 06,2018: AC Immune to Participate in Two Investor Conferences and Provide Scientific Updates at AAT-AD/PD Conference
Dec 01,2017: AC Immune Shares Insights from Key Opinion Leader Meeting on Tau as a Therapeutic and Diagnostic Target in Alzheimer's and other Neurodegenerative Diseases

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
AC Immune SA - Key Facts
AC Immune SA - Key Employees
AC Immune SA - Key Employee Biographies
AC Immune SA - Major Products and Services
AC Immune SA - History
AC Immune SA - Company Statement
AC Immune SA - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
AC Immune SA - Business Description
AC Immune SA - Corporate Strategy
AC Immune SA - SWOT Analysis
SWOT Analysis - Overview
AC Immune SA - Strengths
AC Immune SA - Weaknesses
AC Immune SA - Opportunities
AC Immune SA - Threats
AC Immune SA - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AC Immune SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
AC Immune SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
AC Immune SA, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 02, 2018: AC Immune Reports First Quarter 2018 Financial Results and Corporate Update
Apr 05, 2018: AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer's disease
Mar 20, 2018: AC Immune reports full-year 2017 financial results - successful first year as a public company
Feb 06, 2018: AC Immune to Participate in Two Investor Conferences and Provide Scientific Updates at AAT-AD/PD Conference
Dec 01, 2017: AC Immune Shares Insights from Key Opinion Leader Meeting on Tau as a Therapeutic and Diagnostic Target in Alzheimer's and other Neurodegenerative Diseases
Nov 13, 2017: AC Immune Reports Third Quarter 2017 Financial Results and Corporate Update
Oct 03, 2017: AC Immune Awarded Continuation of 2015 Grant from The Michael J. Fox Foundation for Parkinsons Research
Aug 22, 2017: AC Immune Discovers Next-generation Antibodies Focused On Neurodegenerative Diseases
Aug 09, 2017: AC Immune Reports Second Quarter 2017 Financial Results
Jul 10, 2017: AC immune provides seven updates on its pipeline and technology at the alzheimer's association international conference
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
AC Immune SA, Key Facts
AC Immune SA, Key Employees
AC Immune SA, Key Employee Biographies
AC Immune SA, Major Products and Services
AC Immune SA, History
AC Immune SA, Key Competitors
AC Immune SA, Ratios based on current share price
AC Immune SA, Annual Ratios
AC Immune SA, Annual Ratios (Cont...1)
AC Immune SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
AC Immune SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
AC Immune SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
AC Immune SA, Performance Chart (2013 - 2017)
AC Immune SA, Ratio Charts
AC Immune SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
AC Immune SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report